BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17051139)

  • 21. Decreased glomerular expression of agrin in diabetic nephropathy and podocytes, cultured in high glucose medium.
    Yard BA; Kahlert S; Engelleiter R; Resch S; Waldherr R; Groffen AJ; van den Heuvel LP; van der Born J; Berden JH; Kröger S; Hafner M; van der Woude FJ
    Exp Nephrol; 2001; 9(3):214-22. PubMed ID: 11340306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity.
    Masola V; Zaza G; Secchi MF; Gambaro G; Lupo A; Onisto M
    Biochim Biophys Acta; 2014 Sep; 1843(9):2122-8. PubMed ID: 24937189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High glucose-induced intestinal epithelial barrier damage is aggravated by syndecan-1 destruction and heparanase overexpression.
    Qing Q; Zhang S; Chen Y; Li R; Mao H; Chen Q
    J Cell Mol Med; 2015 Jun; 19(6):1366-74. PubMed ID: 25702768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
    Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The protective role of fucosylated chondroitin sulfate, a distinct glycosaminoglycan, in a murine model of streptozotocin-induced diabetic nephropathy.
    Gomes CL; Leão CL; Venturotti C; Barreira AL; Guimarães G; Fonseca RJ; Fortunato RS; Mourão PA; Delgado AG; Takiya CM; Leite M
    PLoS One; 2014; 9(9):e106929. PubMed ID: 25192337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No change in glomerular heparan sulfate structure in early human and experimental diabetic nephropathy.
    van den Born J; Pisa B; Bakker MA; Celie JW; Straatman C; Thomas S; Viberti GC; Kjellen L; Berden JH
    J Biol Chem; 2006 Oct; 281(40):29606-13. PubMed ID: 16885165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparanase and Syndecan-4 Are Involved in Low Molecular Weight Fucoidan-Induced Angiogenesis.
    Haddad O; Guyot E; Marinval N; Chevalier F; Maillard L; Gadi L; Laguillier-Morizot C; Oudar O; Sutton A; Charnaux N; Hlawaty H
    Mar Drugs; 2015 Oct; 13(11):6588-608. PubMed ID: 26516869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary heparanase activity in patients with Type 1 and Type 2 diabetes.
    Rops AL; van den Hoven MJ; Veldman BA; Salemink S; Vervoort G; Elving LD; Aten J; Wetzels JF; van der Vlag J; Berden JH
    Nephrol Dial Transplant; 2012 Jul; 27(7):2853-61. PubMed ID: 22187315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adult and paediatric patients with minimal change nephrotic syndrome show no major alterations in glomerular expression of sulphated heparan sulphate domains.
    Wijnhoven TJ; Geelen JM; Bakker M; Lensen JF; Rops AL; Kramer AB; Navis G; van den Hoven MJ; van der Vlag J; Berden JH; Wetzels JF; van den Heuvel LP; Monnens LA; van Kuppevelt TH
    Nephrol Dial Transplant; 2007 Oct; 22(10):2886-93. PubMed ID: 17526541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation.
    Parish CR; Freeman C; Ziolkowski AF; He YQ; Sutcliffe EL; Zafar A; Rao S; Simeonovic CJ
    Matrix Biol; 2013 Jun; 32(5):228-33. PubMed ID: 23499527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferator-activated receptor ɣ agonist mediated inhibition of heparanase expression reduces proteinuria.
    Garsen M; Buijsers B; Sol M; Gockeln L; Sonneveld R; van Kuppevelt TH; de Graaf M; van den Born J; Kamps JAAM; van Raalte DH; van der Meer RW; Lamb HJ; Hillebrands JL; Rabelink TJ; Maciej-Hulme ML; Krenning G; Nijenhuis T; van der Vlag J
    EBioMedicine; 2023 Apr; 90():104506. PubMed ID: 36889064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparin.
    Lewis EJ; Xu X
    Diabetes Care; 2008 Feb; 31 Suppl 2():S202-7. PubMed ID: 18227486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of human heparanase in the pathogenesis of diabetic nephropathy.
    Katz A; Van-Dijk DJ; Aingorn H; Erman A; Davies M; Darmon D; Hurvitz H; Vlodavsky I
    Isr Med Assoc J; 2002 Nov; 4(11):996-1002. PubMed ID: 12489489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crosstalk between tumor cells and lymphocytes modulates heparanase expression.
    Theodoro TR; Matos LL; Cavalheiro RP; Justo GZ; Nader HB; Pinhal MAS
    J Transl Med; 2019 Mar; 17(1):103. PubMed ID: 30922347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1.
    de Mestre AM; Staykova MA; Hornby JR; Willenborg DO; Hulett MD
    J Leukoc Biol; 2007 Nov; 82(5):1289-300. PubMed ID: 17656651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dominant-negative CREB inhibits heparanase functionality and melanoma cell invasion.
    Aucoin R; Reiland J; Roy M; Marchetti D
    J Cell Biochem; 2004 Oct; 93(2):215-23. PubMed ID: 15368349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decrease of heparan sulfate staining in the glomerular basement membrane in murine lupus nephritis.
    van Bruggen MC; Kramers K; Hylkema MN; van den Born J; Bakker MA; Assmann KJ; Smeenk RJ; Berden JH
    Am J Pathol; 1995 Mar; 146(3):753-63. PubMed ID: 7534044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of adrenomedullin and receptors in glomerular hyperfiltration in streptozotocin-induced diabetic rats.
    Hiragushi K; Wada J; Eguchi J; Matsuoka T; Yasuhara A; Hashimoto I; Yamashita T; Hida K; Nakamura Y; Shikata K; Minamino N; Kangawa K; Makino H
    Kidney Int; 2004 Feb; 65(2):540-50. PubMed ID: 14717924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nephrin loss in experimental diabetic nephropathy is prevented by deletion of protein kinase C alpha signaling in-vivo.
    Menne J; Meier M; Park JK; Boehne M; Kirsch T; Lindschau C; Ociepka R; Leitges M; Rinta-Valkama J; Holthofer H; Haller H
    Kidney Int; 2006 Oct; 70(8):1456-62. PubMed ID: 16955103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HPSE-1 expression and functionality in differentiating neural cells.
    Moretti M; Sinnappah-Kang ND; Toller M; Curcio F; Marchetti D
    J Neurosci Res; 2006 Mar; 83(4):694-701. PubMed ID: 16429446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.